Precision Partnerships Across the Life Sciences Landscape
Elise Biopharma empowers innovators across the therapeutic development spectrum—from early-stage biotech startups to global biosimilar manufacturers and research institutions. As a full-spectrum CDMO, we bring deep technical insight, regulatory foresight, and scalable infrastructure to each collaboration, ensuring scientific excellence and program success.
Biotechnology Companies
Enabling Innovation from Concept to Clinic
Biotech firms push the boundaries of therapeutic science—and Elise exists to help them translate bold ideas into manufacturable, regulatory-ready products. Whether you’re developing a novel biologic, a fusion protein, or an engineered cytokine, we offer modular, scalable services that accelerate discovery while de-risking scale-up and GMP execution.
What We Provide:
- Early-stage protein engineering and expression screening
- Microbial and mammalian cell line development
- Process optimization, scale-up, and IND-enabling GMP runs
- Analytical method development, comparability, and CMC support
- Flexible batch sizes and tech transfer options to match evolving needs
From bench-scale feasibility studies to Phase I/II clinical production, Elise is the ideal partner for biotech programs needing agility, scientific rigor, and manufacturing excellence.
Animal Health Innovators
Delivering Therapeutic Solutions Beyond Humans
Veterinary biologics and vaccines are no less complex than their human counterparts—and they require the same level of scientific and regulatory rigor. Elise Biopharma supports animal health companies with biologic development services spanning recombinant protein production, vaccine antigen design, and adjuvant-compatible formulation.
Specialized Capabilities for Animal Health:
- Expression of species-specific proteins and antibodies (e.g., canine, bovine, feline)
- Scale-appropriate bioprocessing for veterinary GMP needs
- Vaccine component purification and pathogen-specific safety testing
- Regulatory support tailored to USDA and international veterinary authorities
- Fill/finish formats suitable for field-ready administration
We help animal health clients accelerate development, reduce costs, and deliver innovative therapies that support the wellbeing of companion animals, livestock, and wildlife. Read more about our Animal CDMO Services <— at this page link.
Biosimilar Developers
Empowering Cost-Effective Access to Biologics
Biosimilar development is both a scientific and regulatory challenge—requiring high-fidelity molecule matching, rigorous analytical comparability, and robust manufacturing precision. Elise Biopharma brings deep experience in biosimilar cell line development, process intensification, and dossier-ready analytics.
Support for Biosimilar Success:
- Clone development and expression system optimization for biosimilar targets
- Platform-based purification workflows with consistency and scalability
- Side-by-side critical quality attribute (CQA) profiling with reference molecules
- Regulatory guidance for global submissions (FDA, EMA, WHO, CDSCO)
- Cost-efficient cGMP manufacturing for pilot and commercial-scale supply
Whether you’re reverse-engineering an originator biologic or scaling an established biosimilar platform, Elise provides the tools and insight to ensure your program meets global quality and comparability expectations.
Government & Academic Research Institutions
Translating Discovery into Deliverable Therapies
We proudly support translational science by partnering with academic researchers, public sector labs, and non-profit developers to bring early-stage innovations into the clinic. Elise helps bridge the gap between basic research and regulatory milestones through tailored development programs and accessible CDMO infrastructure.
How We Support Translational Research:
- Custom protein and antibody expression for mechanistic and therapeutic studies
- Cell line development and characterization for academic innovations
- Process development and scale-up compatible with GLP/GMP transition
- IND/IMPD-enabling analytical and documentation support
- Collaborative, IP-sensitive environments with publication- and grant-friendly workflows
By offering industry-grade services to the academic and public sectors, Elise accelerates the development of promising, mission-driven therapies that might otherwise be stalled by resource gaps.
Let’s Build Together!
Elise Biopharma is purpose-built to serve the full spectrum of biotherapeutic innovators—whether you’re a VC-backed biotech with a novel fusion construct, a biosimilar manufacturer looking to streamline scale-up, or a translational lab working toward your first IND.
Contact us today to explore how Elise can tailor its services to your mission.